Semnur Pharmaceuticals, Inc. (SMNR) Operating income 2023–2025
Semnur Pharmaceuticals, Inc. (SMNR) annual operating income history from SEC filings — each fiscal year as reported.
-$160.4MFY2025 · since FY2023: -$3.2M → -$160.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.4M | -3320.4% |
| FY2024 | -$4.7M | -47.8% |
| FY2023 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNR financial trends
SMNR RevenueSMNR Net incomeSMNR Net marginSMNR Gross profitSMNR Gross marginSMNR Operating marginSMNR Operating cash flowSMNR Free cash flowSMNR Capital expendituresSMNR Return on equitySMNR Stock buybacksSMNR Dividends paidSMNR Total assetsSMNR Total liabilitiesSMNR Shareholders’ equitySMNR overview →